Skip to main content
. 2016 Oct 25;7(47):77998–78008. doi: 10.18632/oncotarget.12868

Figure 3. Fluorescence polarization (FP) assay measures affinity of STAT3 inhibitors for the SH2 domain.

Figure 3

A. stattic B. S3I-1757, and C. A18, A26, and niclosamide.